IL-36 mediates immune activation in Sjögren's disease and may represent a novel biomarker of disease
Journal of Leukocyte Biology · 2026
DOI: 10.1093/jleuko/qiaf183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Bayan Alhaddad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Biology, School of Dental Medicine, The University at Buffalo, State University of New York, 516 Biomedical Research Building, Buf…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Interleukin-1, Lymphocyte Activation. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sjögren's International Collaborative Clinical Alliance, National Institutes of Health/National Institute of Dental and Craniofacial Research, NIDCR NIH HHS.
Abstract (Originalsprache)
Sjögren's disease (SjD) is a systemic autoimmune disease. The underlying disease mechanisms remain poorly understood, and there are no curative therapies. MyD88-mediated signaling is essential for SjD, although the pathways that rely on MyD88 are not well characterized. Our objective was to determine if MyD88-dependent IL-1 cytokines mediate inflammation in SjD. Using a SjD mouse model and patient samples, RNA sequencing was performed on salivary tissue and peripheral B cells. Splenocytes from SjD mice were stimulated with IL-36 cytokines and B cell activation was assessed. Finally, ELISAs were employed to measure IL-36 in SjD patient sera. Our data revealed that IL-1 family–associated genes were dysregulated in SjD salivary tissue. Salivary B cells showed upregulation of genes associated with MyD88 and IL-36 activation and peripheral B cells from SjD mice had dysregulated IL-1 signaling networks. Moreover, B cells from SjD mice showed enhanced activation when stimulated with IL-36 cytokines, and splenocytes derived from SjD mice exhibited elevated cytokine secretion. Finally, high levels of IL-36α and IL-36γ were present in SjD patient sera and IL-36α levels discriminated SjD patients from non-SjD control subjects. Therefore, IL-36 contributes to disease, and drugs targeting IL-1 cytokines, particularly IL-36, may represent novel therapeutic targets for SjD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Biology, School of Dental Medicine, The University at Buffalo, State University of New York, 516 Biomedical Research Building, Buffalo, NY 14214, United States.
- Department of Biomedical Science, College of Dentistry, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
- Department of Biostatistics, School of Public Health and Health Professions, The University at Buffalo, State University of New York, 723 Kimball Tower, Buffalo, NY 14214, United States.
- Salivary Disorders Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health Clinical Center, Building 10 Room 1A01, Bethesda, MD 20895, United States.
ORCID-Profile: Jill M Kramer
Förderung
- Sjögren's International Collaborative Clinical Alliance
- National Institutes of Health/National Institute of Dental and Craniofacial Research
- NIDCR NIH HHS
- Intramural NIH HHS
- NIH HHS
- Division of Intramural Research Program of the NIDCR
- University at Buffalo
- NCATS NIH HHS
Zitieren
APA
Alhaddad, B., Wrynn, T., Kiripolsky, J., Kasperek, E. M., Miecznikowski, J. C., Perez, P., Twohig, J., Warner, B. M., Romano, R. A., & Kramer, J. M. (2026). IL-36 mediates immune activation in Sjögren's disease and may represent a novel biomarker of disease. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf183
Vancouver
Alhaddad B, Wrynn T, Kiripolsky J, Kasperek EM, Miecznikowski JC, Perez P, et al. IL-36 mediates immune activation in Sjögren's disease and may represent a novel biomarker of disease. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiaf183
BibTeX
@article{Alhaddad2026,
author = {Alhaddad, Bayan and Wrynn, Theresa and Kiripolsky, Jeremy and Kasperek, Eileen M and Miecznikowski, Jeffrey C and Perez, Paola and Twohig, Joseph and Warner, Blake M and Romano, Rose-Anne and Kramer, Jill M},
title = {IL-36 mediates immune activation in Sjögren's disease and may represent a novel biomarker of disease},
journal = {Journal of Leukocyte Biology},
year = {2026},
doi = {10.1093/jleuko/qiaf183}
}
EUVIMED